Loading…

Salvage interstitial laser thermal therapy under MRI guidance (MRgFLA) for high-intensity focal ultrasound (HIFU) recurrences: feasibility study

While focal therapy (FT) is increasingly endorsed for treating localized prostate cancer in the appropriately selected patient, management of recurrences following FT is not well-established in the literature. This case series describes three patients who received high-intensity focal ultrasound (HI...

Full description

Saved in:
Bibliographic Details
Published in:Clinical imaging 2021-08, Vol.76, p.217-221
Main Authors: Magee, Diana, Perlis, Nathan, Corr, Kateri, Chan, Rosanna, Gertner, Mark, Zisman, Alexander, Jokhu, Sarah, Ghai, Sangeet
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:While focal therapy (FT) is increasingly endorsed for treating localized prostate cancer in the appropriately selected patient, management of recurrences following FT is not well-established in the literature. This case series describes three patients who received high-intensity focal ultrasound (HIFU) for primary treatment followed by focal laser interstitial thermal therapy (FLTT) for salvage therapy treated in the context of an ongoing clinical trial. Evaluation of these reported patients demonstrates that FLTT is feasible in the salvage setting with promising short-term oncologic outcomes and with the potential to preserve functional outcomes. Repeat focal therapy for previous failures is feasible however, it requires sophisticated imaging modalities for the accurate identification of recurrence and treatment of the tumor. •This is the first case series describing the treatment of HIFU failures using focal laser ablation therapy•Focal therapy has resulted in excellent short term oncologic control and preservation of functional status•The management of HIFU failures with focal therapy requires advanced imaging
ISSN:0899-7071
1873-4499
DOI:10.1016/j.clinimag.2021.04.014